当前位置:首页 - 行情中心 - 联亚药业(301569) - 财务分析 - 现金流量表

联亚药业

(301569)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

现金流量表

报告期2026-06-302026-03-312025-12-312025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金518,302,345.56-896,462,037.32434,352,125.22
  收到的税费返还7,195.31-594,505.05595,033.5
  收到其他与经营活动有关的现金2,298,342.84-6,169,044.362,911,387.68
  经营活动现金流入的平衡项目0-00
  经营活动现金流入小计520,607,883.71-903,225,586.73437,858,546.4
  购买商品、接受劳务支付的现金157,076,376.06-307,713,830144,714,876.24
  支付给职工以及为职工支付的现金90,924,280.76-146,697,299.9183,404,089.61
  支付的各项税费34,625,394.38-33,261,326.6722,552,568.6
  支付其他与经营活动有关的现金34,625,130.77-92,974,547.7445,014,570.91
  经营活动现金流出的平衡项目0-00
  经营活动现金流出小计317,251,181.97-580,647,004.32295,686,105.36
  经营活动产生的现金流量净额平衡项目0-00
  经营活动产生的现金流量净额203,356,701.74112,550,500322,578,582.41142,172,441.04
二、投资活动产生的现金流量:
  收回投资收到的现金275,000,000-718,000,000296,000,000
  取得投资收益收到的现金630,298.15-2,495,142.571,209,227.84
  处置固定资产、无形资产和其他长期资产收回的现金净额92,486.73---
  收到的其他与投资活动有关的现金1,896,496,848.64-2,896,123,498.781,327,847,932.6
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计2,172,219,633.52-3,616,618,641.351,625,057,160.44
  购建固定资产、无形资产和其他长期资产支付的现金49,511,659.68-75,297,123.5544,422,374.58
  投资支付的现金275,000,000-672,000,000300,000,000
  支付其他与投资活动有关的现金2,128,572,200-3,111,562,3001,425,350,400
  投资活动现金流出的平衡项目0-00
  投资活动现金流出小计2,453,083,859.68-3,858,859,423.551,769,772,774.58
  投资活动产生的现金流量净额平衡项目0-00
  投资活动产生的现金流量净额-280,864,226.16--242,240,782.2-144,715,614.14
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金--68,000,00068,000,000
  支付其他与筹资活动有关的现金1,537,830-4,703,129.32,127,087.42
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计1,537,830-72,703,129.370,127,087.42
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-1,537,830--72,703,129.3-70,127,087.42
四、汇率变动对现金及现金等价物的影响-15,401,271.61--18,271,678-3,086,345
  现金及现金等价物净增加额平衡项目0-00
五、现金及现金等价物净增加额-94,446,626.03--10,637,007.09-75,756,605.52
  加:期初现金及现金等价物余额223,108,490.08-233,745,497.17233,745,497.17
  期末现金及现金等价物余额平衡项目0-00
  期末现金及现金等价物余额128,661,864.05-223,108,490.08157,988,891.65
补充资料:
  净利润141,027,688.95-227,819,038.04103,090,090.11
  资产减值准备6,688,861-19,257,026.7413,811,079.62
  固定资产和投资性房地产折旧19,503,684.86-34,382,196.6816,961,397.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,503,684.86-34,382,196.6816,961,397.09
  无形资产摊销812,719.92-1,484,363.19730,456.32
  固定资产报废损失-79,912.96-143,435.03690.7
  公允价值变动损失117,295.21--6,317.82-99,630.15
  财务费用-94,705.4--31,058,233.27-14,469,588.02
  投资损失-630,298.15--2,495,142.57-1,209,227.84
  递延所得税-1,137,072.63--661,746.46365,258.76
  其中:递延所得税资产减少-1,137,072.63--661,746.46365,258.76
  存货的减少-11,772,103.23--5,852,997.952,848,145.47
  经营性应收项目的减少24,361,126.91--18,696,225.668,871,306.69
  经营性应付项目的增加-4,267,256.49-37,135,723.2-20,350,776.05
  现金的期末余额128,661,864.05-223,108,490.08157,988,891.65
  减:现金的期初余额223,108,490.08-233,745,497.17233,745,497.17
  现金及现金等价物的净增加额-94,446,626.03--10,637,007.09-75,756,605.52
公告日期2026-09-172026-07-022026-06-122025-12-30
审计意见(境内)标准无保留意见标准无保留意见
TOP↑